Compass Therapeutics Inc (CMPX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Thomas J. Schuetz
Employees:
20
245 FIRST STREET, 3RD FLOOR, CAMBRIDGE, MA 02142
617-500-8099

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops proprietary antibody-based therapeutics to treat multiple human diseases. The company's product candidates include CTX-009, an investigational bispecific antibody, which is in Phase II clinical trial for biliary tract cancers, as well as Phase Ib clinical trials for colorectal and ovarian cancer.

Data derived from most recent annual or quarterly report
Market Cap 251.095 Million Shares Outstanding127.459 Million Avg 30-day Volume 219.068 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.09
Price to Revenue0.0 Debt to Equity0.0068 EBITDA-43.296 Million
Price to Book Value2.4085 Operating Margin0.0 Enterprise Value237.716 Million
Current Ratio18.073 EPS Growth0 Quick Ratio17.401
1 Yr BETA 0.7461 52-week High/Low 5.65 / 1.83 Profit Margin0.0
Operating Cash Flow Growth-112.5678 Free Cash Flow to Firm (FCFF) TTM -38.694 Million Free Cash Flow to Equity (FCFE) TTM-34.066 Million
Altman Z-Score20.3633
Earnings Report2023-11-08

Are you looking for this stock instead?

View SEC Filings from CMPX instead.

View recent insider trading info

Compass Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CMPX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CMPX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-04-24 by LINDAHL RICHARD S
  • 3: filed on 2023-04-24 by LINDAHL RICHARD S
  • 4: filed on 2023-03-10 by SCHUETZ THOMAS J.
  • 4: filed on 2023-02-27 by SCHUETZ THOMAS J.
  • 4: filed on 2023-02-15 by SCHUETZ THOMAS J.
  • 4: filed on 2023-02-10 by WURZER DAVID M
  • 4: filed on 2023-02-09 by CHINIARA ELLEN
  • 4: filed on 2023-02-09 by GRAY MARY ANN
  • 4: filed on 2023-02-09 by GORDON CARL L
  • 4: filed on 2023-02-09 by FERNEAU PHILIP

    • Events (8k)

  • 8-K: filed on 2023-08-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-15:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-24:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-03-10:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-02-24:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-02-10:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-01-19:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-29:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-11-02:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    LINDAHL RICHARD S

    • Director
    		 0 2023-04-21 2

    SCHUETZ THOMAS J. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 6,021,873 2023-03-10 6

    WURZER DAVID M

    • Director
    		 0 2023-02-08 2

    GRAY MARY ANN

    • Director
    		 0 2023-02-08 1

    GORDON CARL L

    • Director
    • 10% Owner
    		 0 2023-02-08 2

    CHINIARA ELLEN

    • Director
    		 0 2023-02-08 1

    BISKER-LEIB VERED CHIEF OPERATING OFFICER

    • Officer
    		 1,484,914 2023-02-08 3

    FERNEAU PHILIP

    • Director
    		 0 2023-02-08 1

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP V LLC

    ORBIMED GENESIS GP LLC

    • Director
    • 10% Owner
    		 18,791,422 2022-11-08 1

    BOYLAN JAMES P

    • Director
    		 0 2022-11-04 1

    SQUINTO STEPHEN P

    • Director
    		 30,000 2022-02-18 0

    KAPLAN BRETT

    • Director
    		 30,000 2022-02-18 0

    KALLED SUSAN CHIEF SCIENTIFIC OFFICER

    • Officer
    		 60,000 2022-02-18 0

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP V LLC

    • Director
    • 10% Owner
    		 12,714,404 2020-06-19 1

    SUNDERLAND JULIE

    • Director
    		 2,212,907 2020-06-17 0

    TOMPKINS MARK N.

    • Director
    • 10% Owner
    		 4,750,000 2018-07-29 0

    JACOBS IAN SETH PRESIDENT, SEC, CEO, & CFO

    • Officer
    • Director
    		 250,000 2018-07-29 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 22:15:03 UTC 3.5217 1.7983 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 21:45:04 UTC 3.5217 1.7983 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 21:15:03 UTC 3.5217 1.7983 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 20:45:05 UTC 3.5217 1.7983 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 20:15:04 UTC 3.5217 1.7983 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 19:45:04 UTC 3.5217 1.7983 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 19:15:03 UTC 0.0 0.0 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 18:45:03 UTC 0.0 0.0 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 18:15:03 UTC 0.0 0.0 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 17:45:03 UTC 3.6114 1.7086 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 17:15:04 UTC 3.6114 1.7086 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 16:45:04 UTC 3.8424 1.4776 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 16:15:03 UTC 3.8424 1.4776 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 15:45:04 UTC 3.8521 1.4679 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 15:15:04 UTC 3.8521 1.4679 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 14:45:04 UTC 3.17 2.15 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 14:15:04 UTC 3.17 2.15 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 13:45:03 UTC 4.0381 1.2819 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 13:15:04 UTC 4.0381 1.2819 300000
    COMPASS THERAPEUTICS INC CMPX 2023-09-29 12:45:05 UTC 4.0381 1.2819 300000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments